JP2011116782A5 - - Google Patents

Download PDF

Info

Publication number
JP2011116782A5
JP2011116782A5 JP2011051093A JP2011051093A JP2011116782A5 JP 2011116782 A5 JP2011116782 A5 JP 2011116782A5 JP 2011051093 A JP2011051093 A JP 2011051093A JP 2011051093 A JP2011051093 A JP 2011051093A JP 2011116782 A5 JP2011116782 A5 JP 2011116782A5
Authority
JP
Japan
Prior art keywords
group
chloro
leaving
oxo
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011051093A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011116782A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2011116782A publication Critical patent/JP2011116782A/ja
Publication of JP2011116782A5 publication Critical patent/JP2011116782A5/ja
Pending legal-status Critical Current

Links

JP2011051093A 2002-09-25 2011-03-09 2’−デオキシグアノシンから2−クロロ−2’−デオキシアデノシンを調製する方法 Pending JP2011116782A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US41391502P 2002-09-25 2002-09-25
US60/413,915 2002-09-25
US41632902P 2002-10-04 2002-10-04
US60/416,329 2002-10-04

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2005501990A Division JP4757632B2 (ja) 2002-09-25 2003-09-25 2’−デオキシグアノシンから2−クロロ−2’−デオキシアデノシンを調製する方法

Publications (2)

Publication Number Publication Date
JP2011116782A JP2011116782A (ja) 2011-06-16
JP2011116782A5 true JP2011116782A5 (https=) 2012-09-06

Family

ID=32045263

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2005501990A Expired - Fee Related JP4757632B2 (ja) 2002-09-25 2003-09-25 2’−デオキシグアノシンから2−クロロ−2’−デオキシアデノシンを調製する方法
JP2011051093A Pending JP2011116782A (ja) 2002-09-25 2011-03-09 2’−デオキシグアノシンから2−クロロ−2’−デオキシアデノシンを調製する方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2005501990A Expired - Fee Related JP4757632B2 (ja) 2002-09-25 2003-09-25 2’−デオキシグアノシンから2−クロロ−2’−デオキシアデノシンを調製する方法

Country Status (7)

Country Link
US (2) US7572909B2 (https=)
EP (1) EP1556400B1 (https=)
JP (2) JP4757632B2 (https=)
AU (1) AU2003275267A1 (https=)
CA (1) CA2540158C (https=)
ES (1) ES2405825T3 (https=)
WO (1) WO2004028462A2 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2405825T3 (es) 2002-09-25 2013-06-03 Brigham Young University Método para la preparación de compuestos 2-halo-2'-desoxiadenosina a partir de 2'-desoxiguanosina
EP3332789B1 (en) 2004-12-22 2022-04-06 Merck Serono SA Cladribine regimen for treating multiple sclerosis
AU2007253254B2 (en) 2006-05-24 2013-01-17 Merck Serono Sa Cladribine regimen for treating multiple sclerosis
DE602006009282D1 (de) 2006-12-15 2009-10-29 Explora Lab Sa Verfahren zur Herstellung von Cladribin
RU2324699C1 (ru) * 2007-02-05 2008-05-20 Институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Россиийской Академии Наук СПОСОБ ПОЛУЧЕНИЯ 2,6-ДИХЛОР-9-(2,3,5-ТРИ-O-АЦЕТИЛ-β-D-РИБОФУРАНОЗИЛ)ПУРИНА
EP2343074A1 (en) 2009-12-23 2011-07-13 Merck Serono S.A. Use of purine analogues for treating airway diseases
RU2649828C1 (ru) * 2017-06-07 2018-04-04 Государственное бюджетное учреждение здравоохранения города Москвы Московский клинический научно-практический центр им. А.С. Логинова Департамента здравоохранения города Москвы Способ лечения волосатоклеточного лейкоза
EP3713582A1 (en) 2017-11-24 2020-09-30 Merck Patent GmbH Cladribine regimen for use intreating progressive forms of multiple sclerosis
CA3194812A1 (en) 2020-09-10 2022-03-17 Merck Patent Gmbh Novel treatment regimen for the treatment of autoimmune disorders
US20240077481A1 (en) 2021-03-03 2024-03-07 Ares Trading S.A. Improved treatment methods using dmds for the treatment of autoimmune diseases, and biomarker for predicting and/or optimising said treatment methods
TW202541818A (zh) 2023-12-14 2025-11-01 瑞士商亞利斯貿易公司 用於治療重症肌無力之克拉屈濱(cladribine)療程

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4760137A (en) 1984-08-06 1988-07-26 Brigham Young University Method for the production of 2'-deoxyadenosine compounds
CA1269659A (en) * 1984-08-06 1990-05-29 Brigham Young University Method for the production of 2'-deoxyadenosine compounds
DE3924424A1 (de) 1989-07-24 1991-01-31 Boehringer Mannheim Gmbh Nucleosid-derivate, verfahren zu deren herstellung, deren verwendung als arzneimittel sowie deren verwendung bei der nucleinsaeure-sequenzierung
US5208327A (en) * 1991-12-18 1993-05-04 Ortho Pharmaceutical Corporation Intermediates useful in a synthesis of 2-chloro-2'-deoxyadenosine
US5602246A (en) * 1992-11-25 1997-02-11 Schering Aktiengesellschaft Process for the preparation of fludarabine or fludarabine phosphate from guanosine
US6252061B1 (en) 1998-03-23 2001-06-26 Reliable Biopharmaceutical, Inc. Process for the production of 2-halo-6-aminopurine derivatives
US6541626B2 (en) * 2001-04-17 2003-04-01 Isis Pharmaceuticals, Inc. Process for selective N-acylation of purine nucleosides
ES2405825T3 (es) 2002-09-25 2013-06-03 Brigham Young University Método para la preparación de compuestos 2-halo-2'-desoxiadenosina a partir de 2'-desoxiguanosina

Similar Documents

Publication Publication Date Title
JP2011116782A5 (https=)
JP2015042636A5 (ja) 有機化合物
JP2015078176A5 (https=)
JP2013506009A5 (https=)
JP2009543861A5 (https=)
EP2383276A4 (en) PROCESS FOR PREPARING A LITHIUM DIFLUORBIC (OXALATO) PHOSPHATE SOLUTION
JP2017515919A5 (https=)
JP2014526533A5 (https=)
JP2015530408A5 (https=)
JP2008514418A5 (https=)
HRP20171167T1 (hr) Priprava intermedijera pirimidina koji služe za proizvodnju macitentana
JP2015501841A5 (https=)
MX369016B (es) Método de extracción de ácido desoxirribonucleico/ácido ribonucleico usando compuestos de amonio cuaternario sililados.
JP2016145229A5 (https=)
WO2012177695A3 (en) Hybrid polymerases having the ability to produce long amplicons
JP2012094862A5 (https=)
RU2015127992A (ru) Способы получения 4-амино-3-галоген-6(замещенных)пиколинатов и 4-амино-5-фтор-3-галоген-6-(замещенных)пиколинатов
JP2013171063A5 (https=)
JP2016523246A5 (https=)
JP2012533618A5 (https=)
JP2012025937A5 (https=)
JP2017019744A5 (https=)
RU2015128095A (ru) Способ получения 4-амино-5-фтор-3-хлор-6-(замещенных)пиколинатов
JP2015127321A5 (https=)
JP2016011992A5 (https=)